Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Wockhardt

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Wockhardt's 2013 sales performance.

India denies Vertex patent on cystic fibrosis drug Orkambi

India denies Vertex patent on cystic fibrosis drug Orkambi

The patent was opposed by the Indian Pharmaceutical Alliance (IPA), a trade organisation representing India's larger pharmaceutical companies, including Cipla, Dr Reddy's Labs, Lupin, Nicholas Piramal, Ranbaxy and Wockhardt.

Opportunities in the medical devices sector in India

Opportunities in the medical devices sector in India Leading private hospitals that are currently controlling the country's healthcare sector include Apollo Hospitals Enterprise, Fortis Healthcare, Wockhardt Hospitals, Max Hospitals, Aravind Eye Hospitals and Manipal Hospitals, among others. .

Lilly wins Cymbalta exclusivity

Lilly filed the suit in 2008 after Wockhardt submitted an abbreviated new drug application with the US Food and Drug Administration (FDA) seeking approval of its generic Cymbalta product. ... Wockhardt last month and has now issued a new order requiring

Takeda settles Actos patent suits

The lawsuits were filed in response to abbreviated new drug applications (ANDA) submitted to the FDA by Mylan, Watson, Ranbaxy, Sandoz, Teva, Alphapharm, Torrent, Dr Reddy's Laboratories, Wockhardt, Synthon, and ... FDA. Takeda's settlements with

Slim pickings

Metoprolol . (Wockhardt). Hypertension, angina. US. N-acetyl-s-farnsylcysteine. Arazine (Rohto Pharmaceutical). Inflammation . Japan.

1 2 3 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

digital launch
How can virtual pharma companies de-risk new product launches?
The risks and challenges involved in taking specialty drugs, biopharmaceuticals and drug/device combinations to market...
Not waving but drowning. Reflections on data curation in the age of information overload
...
digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...

Infographics